147 related articles for article (PubMed ID: 24390133)
1. Different roads, same destination.
Wang B
J Invest Dermatol; 2014 Apr; 134(4):1154-1155. PubMed ID: 24390133
[No Abstract] [Full Text] [Related]
2. Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.
Wang H; Yan L; Zhang G; Chen X; Yang J; Li M; Shen J; Yu M; Huo R; Wang B
J Invest Dermatol; 2013 Nov; 133(11):2642-2644. PubMed ID: 23604100
[No Abstract] [Full Text] [Related]
3. HLA-B*13:01 and the dapsone hypersensitivity syndrome.
Zhang FR; Liu H; Irwanto A; Fu XA; Li Y; Yu GQ; Yu YX; Chen MF; Low HQ; Li JH; Bao FF; Foo JN; Bei JX; Jia XM; Liu J; Liany H; Wang N; Niu GY; Wang ZZ; Shi BQ; Tian HQ; Liu HX; Ma SS; Zhou Y; You JB; Yang Q; Wang C; Chu TS; Liu DC; Yu XL; Sun YH; Ning Y; Wei ZH; Chen SL; Chen XC; Zhang ZX; Liu YX; Pulit SL; Wu WB; Zheng ZY; Yang RD; Long H; Liu ZS; Wang JQ; Li M; Zhang LH; Wang H; Wang LM; Xiao P; Li JL; Huang ZM; Huang JX; Li Z; Liu J; Xiong L; Yang J; Wang XD; Yu DB; Lu XM; Zhou GZ; Yan LB; Shen JP; Zhang GC; Zeng YX; de Bakker PI; Chen SM; Liu JJ
N Engl J Med; 2013 Oct; 369(17):1620-8. PubMed ID: 24152261
[TBL] [Abstract][Full Text] [Related]
4. A case of dapsone hypersensitivity syndrome in an Indian leprosy patient: Retrospective screening reveals the genetic connection with HLA-B*13:01.
Bommakanti J; Namoju R; Jabeen T; Mohammed AK; Kothakoti G; Pashikanti S; Chilaka NK; Avanapu SR
Dermatol Ther; 2020 Nov; 33(6):e13825. PubMed ID: 32535989
[No Abstract] [Full Text] [Related]
5. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
[TBL] [Abstract][Full Text] [Related]
6. Dapsone syndrome.
Dhamija R; Kumar D; Khurana G
Trop Doct; 1995 Oct; 25(4):176-7. PubMed ID: 7502329
[No Abstract] [Full Text] [Related]
7. Dapsone hypersensitivity or viral exanthem?
Ramam M; Srivastava P
Acta Derm Venereol; 2004; 84(4):334-5; author reply 335-6. PubMed ID: 15339092
[No Abstract] [Full Text] [Related]
8. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
[TBL] [Abstract][Full Text] [Related]
9. Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
Krismawati H; Irwanto A; Pongtiku A; Irwan ID; Maladan Y; Sitanggang YA; Wahyuni T; Tanjung R; Sun Y; Liu H; Zhang F; Oktavian A; Liu J
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008746. PubMed ID: 33064728
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.
Liu H; Wang Z; Bao F; Wang C; Sun L; Zhang H; Yu G; Mi Z; Li J; Li L; Zhao Q; Yue Z; Zhao W; Yu W; Cao J; Xiong F; Wang Y; Chai Z; Cheng X; Zhang Y; Fu F; Lang X; Wang X; Irwanto A; Krismawati H; Fu X; Sun Y; You J; Liu J; Pan Q; Chu T; Liu D; Chen S; Shen J; Yan L; Zhang G; Liu J; Zhang F; ; Xiong L; Yang J; Li J; Ke W; Li M; Ning Y; Xiong J; Li M; Xiong M; Yang B; Duan Q; Wang H; Li W; Kuang Y; Li J; Wang L; Cao Q; Xiao P; Xiao B; Zhang L; Lin Z; Wang Y; Shen Y; Yan L; Wu W; Zheng H; Zhan X; Li W; Shang X; Xu Y; Liu Q
JAMA Dermatol; 2019 Jun; 155(6):666-672. PubMed ID: 30916737
[TBL] [Abstract][Full Text] [Related]
11. Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal.
Rao PN; Lakshmi TS
Lepr Rev; 2001 Mar; 72(1):57-62. PubMed ID: 11355519
[TBL] [Abstract][Full Text] [Related]
12. Dapsone hypersensitivity syndrome with coexisting acute hepatitis E.
Chogle A; Nagral A; Soni A; Agale S; Jamadar Z
Indian J Gastroenterol; 2000; 19(2):85-6. PubMed ID: 10812824
[TBL] [Abstract][Full Text] [Related]
13. Dapsone-induced agranulocytosis in a patient of leprosy.
Mishra M; Chhetia R
Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
[No Abstract] [Full Text] [Related]
14. Dapsone agranulocytosis in a leprosy patient.
Hiran S; Pande TK; Pani S; Vishwanathan KA
Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
[TBL] [Abstract][Full Text] [Related]
15. Sparing of tuberculoid leprosy patch in a patient with dapsone hypersensitivity syndrome.
Ng PP; Goh CL
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):646-8. PubMed ID: 9777777
[No Abstract] [Full Text] [Related]
16. Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol.
Krismawati H; Ferdiana A; Irwanto A; Budiawan T; Imaniar C; Wahyuni T; Singh P; Mieras L; Pongtiku A
BMJ Open; 2022 May; 12(5):e057173. PubMed ID: 35545382
[TBL] [Abstract][Full Text] [Related]
17. Side-effects of antileprosy drugs in common use.
Jopling WH
Lepr Rev; 1983 Dec; 54(4):261-70. PubMed ID: 6199637
[No Abstract] [Full Text] [Related]
18. A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome.
Watanabe H; Watanabe Y; Tashiro Y; Mushiroda T; Ozeki T; Hashizume H; Sueki H; Yamamoto T; Utsunomiya-Tate N; Gouda H; Kusakabe Y
J Dermatol Sci; 2017 Dec; 88(3):320-329. PubMed ID: 28870516
[TBL] [Abstract][Full Text] [Related]
19. Dapsone-induced methemoglobinemia in leprosy patients.
Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
[No Abstract] [Full Text] [Related]
20. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
Narasimharao P; Pratap DV; Suneetha S
Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
[No Abstract] [Full Text] [Related]
[Next] [New Search]